Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200427047215N2Phase 3Completed
Phase 3, triple-blind trial of acetaminophen, promethazine, pethidine and lidocaine in None and anxiety disorder (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain after procedure, Pain at 30 minutes after procedure and 2 more. Started Jan 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200427047215N2.